Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML) Meeting Abstract
| Authors: | Dinardo, C. D.; Schuh, A. C.; Stein, E. M.; Montesinos, P.; Wei, A.; De Botton, S.; Zeidan, A. M.; Fathi, A. T.; Quek, L.; Kantarjian, H. M.; Frattini, M. G.; Lersch, F.; Gong, J.; Franovic, A.; Vyas, P.; Dohner, H. |
| Abstract Title: | Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 399s |
| Language: | English |
| ACCESSION: | WOS:000560368303164 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.7501 |
| Notes: | Meeting Abstract: 7501 -- Source: Wos |
